Mohammad Shoukfeh
Cardiovascular Disease · Lubbock, TXNPI 1962405209
Payments from drug & device makers
Across 136 payments — averaging $175.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Esperion Therapeutics, Inc.$14K
- Novartis$6K
- E.r. Squibb & Sons, L.L.C.$2K
- Boston Scientific$642
- Amgen$309
- AstraZeneca$262
- plus $1K from 12 others
What the payments were for
- Food & beverage$2,46095%
- Education$1335%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Esperion Therapeutics, Inc. | 1 | $14,146 |
| Novartis | 18 | $5,826 |
| E.r. Squibb & Sons, L.L.C. | 6 | $1,695 |
| Boston Scientific | 21 | $642 |
| Amgen | 17 | $309 |
| AstraZeneca | 12 | $262 |
| Johnson & Johnson | 13 | $235 |
| Amarin Pharma, Inc. | 14 | $197 |
| Boehringer Ingelheim | 8 | $165 |
| Regeneron Healthcare Solutions, Inc. | 10 | $159 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $55 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Medtronic | 3 | $42 |
| AbbVie(2 entities) | 2 | $35 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Gilead | 1 | $18 |
| Pfizer | 1 | $16 |
| Braemar Manufacturing, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNERGY$209
- GUIDEZILLA$102
How this compares
$23,897 in reported general payments places this provider in the 80th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Lubbock
- Ramin Farzaneh-FarDallas$17.1M
- Jeffrey GladdenDallas$15.8M
- Ann NavarDallas$14.5M
- David BrabhamAmarillo$11.5M
- Justin GrodinDallas$6.2M
- Christie BallantyneHouston$4.6M
- Syed NaqviHouston$3.6M
- Faisal WahidMcKinney$3.4M
- James FeldmanHouston$3.1M
- Fernando BoccalandroOdessa$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.